APM
ONCS

Avidity Partners Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Avidity Partners Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-133,864
Closed -$1.44M – 115
2022
Q3 		$1.44M Hold
133,864
– – 0.03% 89
2022
Q2 		$2.19M Hold
133,864
– – 0.05% 71
2022
Q1 		$3.39M Hold
133,864
– – 0.07% 80
2021
Q4 		$2.83M Hold
133,864
– – 0.06% 88
2021
Q3 		$6.27M Buy
133,864
+6,591
+5% +$334K 0.14% 78
2021
Q2 		$7.87M Sell
127,273
-30,454
-19% -$2.76M 0.21% 78
2021
Q1 		$16.6M Buy
157,727
+69,000
+78% +$9.44M 0.46% 64
2020
Q4 		$12.6M Buy
+88,727
New +$9.46M 0.41% 63

Other funds holding ONCS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avidity Partners Management's ONCS Position: Q4 2022 in Review

Avidity Partners Management sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 133,864 shares — an estimated $1.44M sold.

Avidity Partners Management first reported a position in ONCS in Q4 2020 and held it in 8 quarters. The position peaked at $16.6M in Q1 2021. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

  • Avidity Partners Management reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
  • Avidity Partners Management sold 133,864 OncoSec Medical Incorporated shares in Q4 2022, an estimated $1.44M.
  • Avidity Partners Management first reported a position in OncoSec Medical Incorporated in Q4 2020 and held it in 8 quarters.
  • Avidity Partners Management's OncoSec Medical Incorporated position peaked at $16.6M in Q1 2021.
  • 17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Avidity Partners Management's 13F filing for Q4 2022, filed 14 Feb 2023.